OneMedNet advances commercial launch of Palantir Foundry-powered real-world data platform

Reuters
02/27
<a href="https://laohu8.com/S/ONMD">OneMedNet</a> advances commercial launch of <a href="https://laohu8.com/S/PLTR">Palantir</a> Foundry-powered real-world data platform

OneMedNet Corporation said it is entering the next phase of its commercial launch for its Real-World Data platform powered by Palantir Foundry, and is working to convert customer evaluations into paid subscriptions following a Nov. 10, 2025 demonstration of live feeds, subscription access and AI-driven search. The company reported early evaluation feedback citing analytical depth across integrated clinical and longitudinal datasets, faster cohort feasibility and discovery, streamlined workflows, and quicker onboarding of data partners. OneMedNet said it is expanding subscription contracts, including multi-year deals representing millions in incremental recurring revenue, and that its iRWD network now includes more than 2,130 healthcare sites. The company also said datasets on the platform are continuously connected to sources in real time, providing longitudinal access spanning more than 20 years of historical data and extending three years forward.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602270850PRIMZONEFULLFEED9662683) on February 27, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10